Major Interest in Shares

RNS Number : 0125O
Alliance Pharma PLC
22 June 2010
 



For immediate release

22 June 2010

 

ALLIANCE PHARMA PLC

("Alliance" or the "Company")

 

Major interest in shares

 

Alliance Pharma plc (AIM: APH), the speciality pharmaceutical company, was today informed that Nigel Wray purchased, on 21 June 2010, 800,000 ordinary shares of 1p each in the Company. 

 

Mr Wray's resultant shareholding is 26,069,995 ordinary shares, equivalent to 11.26% of the Company's issued share capital.

 

Mr Wray's ordinary shares are held as follows:

 

Nominee

Number of ordinary shares

 

Pershing Nominees Limited

Smith & Williamson Nominees Limited

Roy Nominees Limited

 

 

9,405,407

50,000

16,614,588

 

 

For further information:

 

Alliance Pharma plc

+ 44 (0) 1249 466966

John Dawson, Chief Executive Officer


Richard Wright, Finance Director


www.alliancepharma.co.uk




Buchanan Communications

+ 44 (0) 20 7466 5000

Mark Court / Stasa Filiplic




Numis Securities Limited

+ 44 (0) 20 7260 1000

Nominated Adviser: Michael Meade / Brent Nabbs


Corporate Broking: David Poutney


 

Notes to editors:

 

About Alliance

Alliance, founded in 1998, is an AIM listed speciality pharmaceutical company based in Chippenham, Wiltshire, UK. The Company has a strong track record of acquiring the rights to established niche products and owns or licenses the rights to more than 50 pharmaceutical products and continues to explore opportunities to expand the range.

 

Alliance's products are prescribed in the treatment of a wide range of conditions and include products used in the treatment of dermatological conditions, in oncology, in childbirth, in the prevention of heart disease, in Parkinson's disease, in nutrition and in nasal infections.  Alliance's sales are mainly prescription driven.  Its products are distributed both to hospitals directly and to pharmaceutical wholesalers, which in turn service both hospital and retail pharmacies with their prescription requirements.

 

Alliance joined the AIM market of the London Stock Exchange in December 2003 and trades under the symbol APH.


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLSELSUEFSSEFM
UK 100